Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRenmin Hospital of Wuhan University

About this trial

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

Eligibility criteria

Qualifiers

Male or female aged 18 years or older who undergo upper endoscopy.

Disqualifiers

1)No contact information or invalid contact information.

2) The surveillance interval cannot be determined according to the surveillance guidelines, including no upper gastrointestinal pathology, therapeutic endoscopy or with history of previous gastrectomy, esophagectomy, or ESD, no dysplasia degrees, no biopsy sites, non-epithelial lesions, duodenal lesions, ulcer and so on.

3) Needless for surveillance or others.

4) High-grade intraepithelial neoplasia or cancer of the esophagus or stomach.

Trial design

Treatments tested in this trial

  • AI based automatic surveillance (AS) system (ENDOANGEL-AS)
  • Manually remind the patients

Treatment groups

1,460 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Renmin Hospital of Wuhan University

Lead sponsor

Shanghai Pudong Hospital

Collaborator

The Eighth Hospital of Wuhan

Collaborator

Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus

Collaborator